drugset / Trial / NCT07094958

Efficacy of Stromal Vascular Fraction on Acne Scar Correction

NCT07094958

Not yet recruiting 16 enrolled Seoul National University Hospital
RandomizedCrossoverSingle-blindTreatment

Summary

This study aims to evaluate the efficacy and safety of intradermal injection of autologous stromal vascular fraction (SVF) in the treatment of atrophic acne scars. SVF is a heterogeneous cell population derived from adipose tissue, containing various regenerative and immunomodulatory cells, including mesenchymal stem cells, endothelial progenitor cells, and pericytes. In this prospective, randomized, split-face clinical trial, participants with atrophic acne scars will receive SVF injections on one side of the face and normal saline (NS) injections on the contralateral side as a control. Clinical efficacy will be assessed through blinded scar counts, digital imaging, and histological evaluations including epidermal and dermal regenerative markers. The study is designed to investigate whether SVF provides superior clinical improvement compared to placebo.

Timeline

Start
2025-07
Primary completion
2025-12
Completion
2026-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy Intrathecal

Indications